Protagen Diagnostics Overview
- Founded
- 1997

- Status
- Acquired/Merged
- Employees
- 32

- Latest Deal Type
- M&A
- Financing Rounds
- 8
Protagen Diagnostics General Information
Description
Developer of diagnostic tests designed to provide treatment of autoimmune diseases. The company's biomarker discovery platform is used for the detection of autoantibodies in individuals undergoing cancer immunotherapy, as a means of predicting treatment response and guiding therapeutic decisions, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.
Contact Information
(Operating Subsidiary)
- Otto-Hahn-Street 15
- 44227 Dortmund
- Germany
Protagen Diagnostics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Protagen Diagnostics‘s full profile, request access.
Request a free trialProtagen Diagnostics Comparisons
Industry
0000000
0000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialProtagen Diagnostics Competitors (13)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
OncoDNA | Venture Capital-Backed | Gosselies, Belgium | 00 | 000.00 | 0000000000 0 | 000.00 |
0000000 (000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
0000000 | Venture Capital-Backed | Cambridge, MA | 000 | 00000000000 | 000 | |
0000000 | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | 00 | 000.00 | 00000000000 | 000.00 |
000000 | Venture Capital-Backed | Seattle, WA | 00 | 00000 | 0000000000 0 | 00000 |
Protagen Diagnostics Executive Team (8)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hans-Dieter Zucht | Head, Technology | ||
Peter Schulz-Knappe MD | Chief Scientific Officer |
Protagen Diagnostics Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
00000000 0000000000 00.0 | Protagen Diagnostics | Chairman | 000 0000 |
0000 000000 00.0 | Self | Board Member | 000 0000 |
000000 0000000 | Self | Board Member | 000 0000 |
00000000 0000 | Protagen Diagnostics | Board Member | 000 0000 |
000000 0000000 00.0 | Self | Board Member | 000 0000 |
Protagen Diagnostics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialProtagen Diagnostics Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Protagen Diagnostics‘s full profile, request access.
Request a free trial